Related Experiment Video
Updated: Apr 19, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
A highly sensitive x-ray imaging modality for hepatocellular carcinoma detection in vitro
Danielle Rand1, Edward G Walsh, Zoltan Derdak
1Department of Chemistry, Brown University, 324 Brook Street, Providence, Rhode Island 02912, USA.
Spatial frequency heterodyne imaging (SFHI) shows promise for medical diagnostics. This novel x-ray scatter imaging technique offers significantly higher sensitivity than conventional methods, approaching MRI levels.
Area of Science:
- Medical Imaging
- Radiology
- Biomedical Engineering
Background:
- Conventional x-ray imaging relies on absorption, rejecting scattered x-rays.
- Magnetic Resonance Imaging (MRI) offers high sensitivity but is costly.
- There is a need for sensitive, cost-effective diagnostic imaging innovations.
Purpose of the Study:
- To evaluate the sensitivity of spatial frequency heterodyne imaging (SFHI) for hepatocellular carcinoma detection.
- To compare SFHI's sensitivity against conventional x-ray imaging and MRI.
- To assess SFHI's potential as a cost-effective alternative to MRI.
Main Methods:
- Utilized numerical processing to generate x-ray scatter images.
- Applied SFHI to hepatocellular carcinoma models labeled with nanoparticle contrast agents.
- Compared SFHI sensitivity with absorption-based x-ray imaging and MRI.
Main Results:
- SFHI images were produced exclusively from scattered x-rays.
- SFHI demonstrated sensitivity an order of magnitude greater than absorption-based x-ray imaging.
- SFHI achieved sensitivity approximately equal to that of MRI.
Conclusions:
- SFHI is a novel x-ray imaging modality utilizing scattered x-rays.
- SFHI shows superior sensitivity compared to conventional x-ray absorption imaging.
- SFHI presents a potential cost-effective alternative to MRI, especially where MRI access is limited.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
12:57X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
Published on: December 9, 2022